Atlas market file · Etf · United States
Virtus Biotech ETFBBP
- Last close
- 98.3065
- Change
- +1.48%
- 96-bar range
- 77.97 – 105.21
- As of
- 6 Aug 2026
Virtus Biotech ETF is an exchange-traded fund listed as BBP on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
BBP
Etf · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+53.73% over the window).
Source rail: Yahoo Finance chart API (BBP). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for BBP. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
BBP public profile
Exchange-traded fund. Virtus Biotech ETF is connected to current market context, cited company sources and its retained research file.
Virtus Biotech ETF trades as BBP on AMEX. Virtus Biotech ETF (BBP) has a latest verified close of 98.3065, up 1.48%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. BBP stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Virtus Biotech ETF today
The Virtus Biotech ETF (BBP) is listed on Nasdaq and its regulatory filings are available on the SEC EDGAR system. The fund's expense ratio and fee structure can be examined through the FINRA Fund Analyzer, a tool designed for comparing fund costs.
BBP tracks an index of biotechnology companies, offering investors exposure to a sector that promises medical breakthroughs but also carries significant concentration risk. The ETF's performance depends on the underlying index methodology and the stocks it holds.
The FINRA Fund Analyzer provides data on the fund's expense ratio, which is a key factor in long-term returns. The SEC EDGAR search yields prospectuses and statements of additional information that detail the fund's investment strategy and risks.
The Nasdaq market activity page shows real-time price and volume, giving insight into liquidity. The bid-ask spread and trading volume are indicators of how easily the ETF can be bought or sold.
No specific financial figures were supplied in this run, so the analysis remains at the level of the wrapper. The actual holdings, AUM, and performance data would deepen the file. The evidence currently available establishes the fund's identity and the sources where further detail can be found.
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
BBP technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on BBP
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep BBP research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
BBP FAQ
What is Virtus Biotech ETF (BBP)?Virtus Biotech ETF (BBP) has a latest verified close of 98.3065, up 1.48%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed...
Virtus Biotech ETF (BBP) has a latest verified close of 98.3065, up 1.48%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for BBP?Virtus Biotech ETF (BBP) has a latest verified close of 98.3065, up 1.48%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Virtus Biotech ETF (BBP) has a latest verified close of 98.3065, up 1.48%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. BBP stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the BBP page updated?The BBP public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The BBP public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for BBP?The BBP file starts with Nasdaq Trader and TradingView AMEX:BBP. The page separates verified market context from company evidence and shows open evidence gaps instead...
The BBP file starts with Nasdaq Trader and TradingView AMEX:BBP. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on BBP?Yes. The workstation can open BBP, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open BBP, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this BBP page investment advice?No. The BBP page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The BBP page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →